Papadopoulos, G. E.; Ninios, I.; Leptopoulos, E.; Papazoglou, K.; Konstantinidis, K.; Evangelou, S.; Ioannidis, A.; Ninios, V. Propensity-Matched Comparison of Percutaneous Versus Surgical Access for Transfemoral Transcatheter Aortic Valve Replacement (TAVR). Preprints2024, 2024080452. https://doi.org/10.20944/preprints202408.0452.v1
APA Style
Papadopoulos, G. E., Ninios, I., Leptopoulos, E., Papazoglou, K., Konstantinidis, K., Evangelou, S., Ioannidis, A., & Ninios, V. (2024). Propensity-Matched Comparison of Percutaneous Versus Surgical Access for Transfemoral Transcatheter Aortic Valve Replacement (TAVR). Preprints. https://doi.org/10.20944/preprints202408.0452.v1
Chicago/Turabian Style
Papadopoulos, G. E., Andreas Ioannidis and Vlasis Ninios. 2024 "Propensity-Matched Comparison of Percutaneous Versus Surgical Access for Transfemoral Transcatheter Aortic Valve Replacement (TAVR)" Preprints. https://doi.org/10.20944/preprints202408.0452.v1
Abstract
Background: Transcatheter aortic valve replacement (TAVR) is a proven treatment for severe aortic stenosis (AS). Transfemoral access is the most prevalent method, achieved either surgically or percutaneously. This study compares in-hospital outcomes and length of stay between surgical cut-down and fully percutaneous approaches. Methods: This retrospective, propensity-matched study analyzed medical records of all patients who underwent transfemoral TAVR at our center from January 2019 to December 2023. Outcomes were assessed based on Valve Academic Research Consortium-2 (VARC-2) consensus criteria. Results: 251 TAVR patients (77 propensity score matching pairs) were included (55% female) with a median (IQR) age of 80 (11) years. Surgical cut-down showed fewer vascular complications, bleeding, and transfusions. No death, stroke, atrial fibrillation (AF), or need for pacemaker was reported in this group. Fewer mean hospitali-zation days were observed in the total cohort over the years (p< 0.001). This reduction was more pronounced after 2021 when the surgical approach was adopted. Mean hospitalization days were 6.40 ±6.46 for percutaneous and 4.34 ±1.61 for surgical groups (p< 0.001). Conclusions: Surgical cut-down for TAVR femoral access yields superior outcomes and shorter hospital stays compared to fully percutaneous methods.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
